A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Chronic Urinary Tract Infections (UTI)
SH
JD
Overseen ByJordan Daniels, MS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: ProgenaBiome
No Placebo Group
Trial Summary
What is the purpose of this trial?
Correlation of Microbiome to Chronic Urinary Tract Infections (UTI) via Relative Abundance Found in Microbiome Sequencing
Research Team
SH
Sabine Hazan, MD
Principal Investigator
ProgenaBiome
Eligibility Criteria
Inclusion Criteria
Male or female patients age 18 and older.
Signed informed consent by patient
Diagnosis of chronic UTIs by a physician based upon urinalysis and/or urine culture.
Treatment Details
Interventions
- No Intervention (Microbiome Modulation)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Chronic UTIExperimental Treatment1 Intervention
Patients who have been diagnosed with chronic urinary tract infections (UTI).
Find a Clinic Near You
Who Is Running the Clinical Trial?
ProgenaBiome
Lead Sponsor
Trials
46
Recruited
5,400+